Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational Study

NCT01378338 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01378338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01378338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
September 30, 2013
Enrollment
855 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

the aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi